Vesicular erythema migrans

N. S. Goldberg, G. Forseter, R. B. Nadelman, I. Schwartz, Ulrich P. Jorde, D. McKenna, D. Holmgren, S. Bittker, M. Montecalvo, G. P. Wormser

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background. - Lyme disease is the most common vector-borne disease in the United States. The characteristic rash, erythema migrans, is an early sign of the disease. Clinical criteria remain the 'gold standard' for diagnosis at this stage of illness. Observations. - Five (8%) of 65 patients with erythema migrans seen in a Lyme disease diagnostic center in Westchester County, New York, had a lesion with vesicles. Borrelia burgdorferi was cultured from two of five. In one case the positive culture came from a swab of the blister fluid. Conclusions. - Recognition of erythema migrans and its variants is important, since early treatment of Lyme disease may prevent late complications. Vesicular erythema migrans should be added to the differential diagnosis of inflammatory vesicular rashes in the appropriate clinical setting.

Original languageEnglish (US)
Pages (from-to)1495-1498
Number of pages4
JournalArchives of Dermatology
Volume128
Issue number11
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Erythema
Lyme Disease
Exanthema
Disease Vectors
Borrelia burgdorferi
Blister
Differential Diagnosis
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Goldberg, N. S., Forseter, G., Nadelman, R. B., Schwartz, I., Jorde, U. P., McKenna, D., ... Wormser, G. P. (1992). Vesicular erythema migrans. Archives of Dermatology, 128(11), 1495-1498. https://doi.org/10.1001/archderm.128.11.1495

Vesicular erythema migrans. / Goldberg, N. S.; Forseter, G.; Nadelman, R. B.; Schwartz, I.; Jorde, Ulrich P.; McKenna, D.; Holmgren, D.; Bittker, S.; Montecalvo, M.; Wormser, G. P.

In: Archives of Dermatology, Vol. 128, No. 11, 1992, p. 1495-1498.

Research output: Contribution to journalArticle

Goldberg, NS, Forseter, G, Nadelman, RB, Schwartz, I, Jorde, UP, McKenna, D, Holmgren, D, Bittker, S, Montecalvo, M & Wormser, GP 1992, 'Vesicular erythema migrans', Archives of Dermatology, vol. 128, no. 11, pp. 1495-1498. https://doi.org/10.1001/archderm.128.11.1495
Goldberg NS, Forseter G, Nadelman RB, Schwartz I, Jorde UP, McKenna D et al. Vesicular erythema migrans. Archives of Dermatology. 1992;128(11):1495-1498. https://doi.org/10.1001/archderm.128.11.1495
Goldberg, N. S. ; Forseter, G. ; Nadelman, R. B. ; Schwartz, I. ; Jorde, Ulrich P. ; McKenna, D. ; Holmgren, D. ; Bittker, S. ; Montecalvo, M. ; Wormser, G. P. / Vesicular erythema migrans. In: Archives of Dermatology. 1992 ; Vol. 128, No. 11. pp. 1495-1498.
@article{39c56b8183f74a389da652de0ef45600,
title = "Vesicular erythema migrans",
abstract = "Background. - Lyme disease is the most common vector-borne disease in the United States. The characteristic rash, erythema migrans, is an early sign of the disease. Clinical criteria remain the 'gold standard' for diagnosis at this stage of illness. Observations. - Five (8{\%}) of 65 patients with erythema migrans seen in a Lyme disease diagnostic center in Westchester County, New York, had a lesion with vesicles. Borrelia burgdorferi was cultured from two of five. In one case the positive culture came from a swab of the blister fluid. Conclusions. - Recognition of erythema migrans and its variants is important, since early treatment of Lyme disease may prevent late complications. Vesicular erythema migrans should be added to the differential diagnosis of inflammatory vesicular rashes in the appropriate clinical setting.",
author = "Goldberg, {N. S.} and G. Forseter and Nadelman, {R. B.} and I. Schwartz and Jorde, {Ulrich P.} and D. McKenna and D. Holmgren and S. Bittker and M. Montecalvo and Wormser, {G. P.}",
year = "1992",
doi = "10.1001/archderm.128.11.1495",
language = "English (US)",
volume = "128",
pages = "1495--1498",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "11",

}

TY - JOUR

T1 - Vesicular erythema migrans

AU - Goldberg, N. S.

AU - Forseter, G.

AU - Nadelman, R. B.

AU - Schwartz, I.

AU - Jorde, Ulrich P.

AU - McKenna, D.

AU - Holmgren, D.

AU - Bittker, S.

AU - Montecalvo, M.

AU - Wormser, G. P.

PY - 1992

Y1 - 1992

N2 - Background. - Lyme disease is the most common vector-borne disease in the United States. The characteristic rash, erythema migrans, is an early sign of the disease. Clinical criteria remain the 'gold standard' for diagnosis at this stage of illness. Observations. - Five (8%) of 65 patients with erythema migrans seen in a Lyme disease diagnostic center in Westchester County, New York, had a lesion with vesicles. Borrelia burgdorferi was cultured from two of five. In one case the positive culture came from a swab of the blister fluid. Conclusions. - Recognition of erythema migrans and its variants is important, since early treatment of Lyme disease may prevent late complications. Vesicular erythema migrans should be added to the differential diagnosis of inflammatory vesicular rashes in the appropriate clinical setting.

AB - Background. - Lyme disease is the most common vector-borne disease in the United States. The characteristic rash, erythema migrans, is an early sign of the disease. Clinical criteria remain the 'gold standard' for diagnosis at this stage of illness. Observations. - Five (8%) of 65 patients with erythema migrans seen in a Lyme disease diagnostic center in Westchester County, New York, had a lesion with vesicles. Borrelia burgdorferi was cultured from two of five. In one case the positive culture came from a swab of the blister fluid. Conclusions. - Recognition of erythema migrans and its variants is important, since early treatment of Lyme disease may prevent late complications. Vesicular erythema migrans should be added to the differential diagnosis of inflammatory vesicular rashes in the appropriate clinical setting.

UR - http://www.scopus.com/inward/record.url?scp=0026440626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026440626&partnerID=8YFLogxK

U2 - 10.1001/archderm.128.11.1495

DO - 10.1001/archderm.128.11.1495

M3 - Article

C2 - 1444504

AN - SCOPUS:0026440626

VL - 128

SP - 1495

EP - 1498

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 11

ER -